Clinical trial
Radiation Therapy With or Without Temozolomide in Treating Older Patients With…
NCT00482677 · Canadian Cancer Trials Group, Other · Completed
Key facts
| NCT number | NCT00482677 |
|---|---|
| Title | Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients |
| Lead sponsor | Canadian Cancer Trials Group, Other |
| Collaborators | European Organisation for Research and Treatment of Cancer - EORTC Trans Tasman Radiation Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Genetic, Procedure, Radiation |
| Interventions | temozolomide, DNA methylation analysis, quality-of-life assessment, Radiation |
| Enrollment | 562 |
| Start date | Nov 14, 2007 |
| Primary completion | Mar 1, 2016 |
| Completion | Aug 10, 2016 |
| First posted | Jun 5, 2007 |
| Last update posted | Aug 22, 2023 |
| Countries | Canada, Germany, Japan, Netherlands |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: